A pdgfr inhibitor for the treatment of pulmonary arterial hypertension

Ended Project Grant Awarded Last action

Award ID
R43HL102946
Recipient
Awarding agency
Obligated
$351,008

Award facts

Assistance listing
93.838 Lung Diseases Research
Completion date
Place of performance
Mellenville, NY 12544, USA

Award details come from USAspending.gov.

Quick answers

Who received award R43HL102946?

R43HL102946 was awarded to Pulmokine, Inc. by National Institutes of Health (Department of Health and Human Services) on August 1, 2010.

How much is award R43HL102946 worth?

$351,008 has been obligated on R43HL102946.

On GovTribe

See this award's full record

  • Every transaction and subaward
  • The recipient's other awards and teaming partners
  • Similar grant awards
  • Ask GovTribe AI about this award